News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
762,031 Results
Type
Article (53214)
Company Profile (351)
Press Release (708447)
Multimedia
Podcasts (115)
Webinars (23)
Section
Business (211952)
Career Advice (2359)
Deals (36425)
Drug Delivery (143)
Drug Development (84143)
Employer Resources (200)
FDA (16850)
Job Trends (15523)
News (358382)
Policy (34189)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2857)
Academic (2)
Accelerated approval (42)
Adcomms (29)
Allergies (165)
Alliances (52083)
ALS (199)
Alzheimer's disease (1819)
Antibody-drug conjugate (ADC) (382)
Approvals (17140)
Artificial intelligence (655)
Autoimmune disease (231)
Automation (51)
Bankruptcy (372)
Best Places to Work (11944)
BIOSECURE Act (21)
Biosimilars (206)
Biotechnology (227)
Bladder cancer (179)
Brain cancer (66)
Breast cancer (699)
Cancer (5428)
Cardiovascular disease (455)
Career advice (1999)
Career pathing (45)
CAR-T (316)
CDC (67)
Celiac Disease (2)
Cell therapy (839)
Cervical cancer (43)
Clinical research (71913)
Collaboration (1991)
Company closure (5)
Compensation (1276)
Complete response letters (71)
COVID-19 (2887)
CRISPR (104)
C-suite (1017)
Cystic fibrosis (151)
Data (7152)
Decentralized trials (3)
Denatured (42)
Depression (157)
Dermatology (58)
Diabetes (555)
Diagnostics (7091)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (316)
Drug pricing (209)
Drug shortages (31)
Duchenne muscular dystrophy (272)
Earnings (92350)
Editorial (68)
Employer branding (25)
Employer resources (170)
Events (123374)
Executive appointments (1072)
FDA (20315)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1687)
Gene editing (225)
Generative AI (59)
Gene therapy (687)
GLP-1 (1079)
Government (5033)
Grass and pollen (6)
Guidances (397)
Healthcare (19556)
HIV (74)
Huntington's disease (56)
IgA nephropathy (93)
Immunology and inflammation (294)
Immuno-oncology (84)
Indications (157)
Infectious disease (3218)
Inflammatory bowel disease (213)
Inflation Reduction Act (16)
Influenza (135)
Intellectual property (279)
Interviews (377)
IPO (16962)
IRA (54)
Job creations (3906)
Job search strategy (1675)
JPM (64)
Kidney cancer (18)
Labor market (101)
Layoffs (598)
Leadership (40)
Legal (8241)
Liver cancer (102)
Longevity (28)
Lung cancer (729)
Lymphoma (411)
Machine learning (54)
Management (65)
Manufacturing (945)
MASH (182)
Medical device (14147)
Medtech (14226)
Mergers & acquisitions (20615)
Metabolic disorders (1452)
mRNA (192)
Multiple sclerosis (175)
NASH (23)
Neurodegenerative disease (403)
Neuropsychiatric disorders (100)
Neuroscience (3255)
Neurotech (1)
NextGen: Class of 2026 (6839)
Non-profit (4763)
Now hiring (74)
Obesity (693)
Opinion (306)
Ovarian cancer (189)
Pain (234)
Pancreatic cancer (259)
Parkinson's disease (351)
Partnered (35)
Patents (561)
Patient recruitment (605)
Peanut (62)
People (61875)
Pharmaceutical (71)
Pharmacy benefit managers (34)
Phase 1 (22640)
Phase 2 (31567)
Phase 3 (23448)
Pipeline (7181)
Policy (334)
Postmarket research (2680)
Preclinical (9933)
Press Release (72)
Prostate cancer (280)
Psychedelics (53)
Radiopharmaceuticals (309)
Rare diseases (1022)
Real estate (6343)
Recruiting (79)
Regulatory (25957)
Reports (70)
Research institute (2640)
Resumes & cover letters (409)
Rett syndrome (32)
RNA editing (18)
RSV (89)
Schizophrenia (168)
Series A (284)
Series B (209)
Service/supplier (13)
Sickle cell disease (111)
Special edition (25)
Spinal muscular atrophy (173)
Sponsored (48)
Startups (3901)
State (2)
Stomach cancer (19)
Supply chain (121)
Tariffs (87)
The Weekly (71)
Vaccines (1137)
Venture capital (103)
Weight loss (446)
Women's health (111)
Worklife (21)
Date
Today (56)
Last 7 days (651)
Last 30 days (2738)
Last 365 days (30823)
2026 (8216)
2025 (31090)
2024 (36300)
2023 (41230)
2022 (52393)
2021 (56972)
2020 (55462)
2019 (48187)
2018 (36412)
2017 (33603)
2016 (33336)
2015 (39402)
2014 (33037)
2013 (28420)
2012 (30559)
2011 (31194)
2010 (29636)
Location
Africa (861)
Alabama (92)
Alaska (7)
Arizona (342)
Arkansas (14)
Asia (42436)
Australia (7098)
California (12435)
Canada (3548)
China (1261)
Colorado (533)
Connecticut (532)
Delaware (369)
Europe (93196)
Florida (1862)
Georgia (408)
Hawaii (4)
Idaho (63)
Illinois (979)
India (82)
Indiana (573)
Iowa (23)
Japan (496)
Kansas (133)
Kentucky (47)
Louisiana (41)
Maine (73)
Maryland (1528)
Massachusetts (9031)
Michigan (368)
Minnesota (705)
Mississippi (7)
Missouri (141)
Montana (37)
Nebraska (29)
Nevada (139)
New Hampshire (86)
New Jersey (3338)
New Mexico (30)
New York (3303)
North Carolina (1628)
North Dakota (10)
Northern California (6125)
Ohio (374)
Oklahoma (23)
Oregon (42)
Pennsylvania (2512)
Puerto Rico (26)
Rhode Island (50)
South America (1220)
South Carolina (76)
South Dakota (1)
Southern California (4881)
Tennessee (203)
Texas (1971)
United States (44411)
Utah (374)
Vermont (1)
Virginia (306)
Washington D.C. (85)
Washington State (997)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
762,031 Results for "human genome sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Direct Genome-Scale Mapping of Endonuclease Activity of the Human LINE-1 ORF2p Endonuclease
February 25, 2026
·
3 min read
Press Releases
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
December 22, 2025
·
4 min read
Press Releases
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer’s Disease Program
• Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical Trials • Consistent Anti-Inflammatory Effects Demonstrate Translation from Animal Models to Three-Dimensional Human Brain Tissue Systems
March 23, 2026
·
7 min read
Press Releases
Abinopharm, Inc. Releases AbinoNutra® NMN White Paper Following FDA Reinstatement and Human Clinical Trial Evidence
February 2, 2026
·
3 min read
Press Releases
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World’s First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies
April 2, 2026
·
6 min read
Press Releases
Seaport Therapeutics Announces Science Translational Medicine Peer-Reviewed Publication Featuring GlyphAlloTM (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
March 26, 2026
·
6 min read
Press Releases
OCHRE BIO COMPLETES HUMAN LIVER FUNCTIONAL GENOMICS AND SINGLE-CELL DATASETS IN PARTNERSHIP WITH GSK
November 18, 2025
·
2 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
March 26, 2026
·
10 min read
Press Releases
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
March 23, 2026
·
4 min read
Press Releases
Allosteric Bioscience, Inc. Targets Optimizing Aging and Longevity: Quantum Computing, Advanced AI, Genomics
March 5, 2026
·
1 min read
1 of 76,204
Next
